China Pharma (CPHI)

Add to Watchlists Create an Alert
0.212 -0.02  -7.79%   AMEX May 23, 8:00PM BATS Real time Currency in USD

China Pharma Debt to Equity Ratio:

0.0321 for Dec. 31, 2012
View Full Chart

China Pharma Debt to Equity Ratio Chart

    China Pharma Historical Debt to Equity Ratio Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 0.0321
    Sept. 30, 2012 0.0265
    June 30, 2012 0.0267
    March 31, 2012 0.0271
    Dec. 31, 2011 0.0276
    Sept. 30, 2011 0.0288
    June 30, 2011 0.0295
    March 31, 2011 0.0307
    Dec. 31, 2010 0.0321
    Sept. 30, 2010 0.027
    June 30, 2010 0.037
    March 31, 2010 0.0391
    Dec. 31, 2009 0.0433
    Sept. 30, 2009 0.0446
    June 30, 2009 0.0319
       
    March 31, 2009 0.0337
    Dec. 31, 2008 0.0355
    Sept. 30, 2008 0.00
    June 30, 2008 0.0412
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Sept. 30, 2005 Go Pro

    About Debt to Equity Ratio

    Leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. A low debt to equity ratio indicates lower risk, because debt holders have less claims on the company's assets. A debt to equity ratio of 5 means that debt holders have a 5 times more claim on assets than equity holders.

    A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.

    It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
    Learn More

    Get data for

    CPHI Debt to Equity Ratio Benchmarks

    Companies
    GlaxoSmithKline 2.886
    Tetraphase Pharmaceuticals
    Zoetis 5.142

    CPHI Debt to Equity Ratio Rankings

    Overall 80th percentile
    1546 of 8009
    Sector 63rd percentile
    252 of 687 in Healthcare
    Industry 70th percentile
    16 of 55 in Drug Manufacturers - Major

    CPHI Debt to Equity Ratio Range, Past 5 Years

    Minimum 0.00 Sep 2008
    Maximum 0.0446 Sep 2009
    Average 0.0313